The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg
Crossref DOI link: https://doi.org/10.1186/s13098-017-0242-0
Published Online: 2017-05-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mancini, Marcio C.
de Melo, Maria Edna
Funding for this research was provided by:
Novo Nordisk Farmacêutica do Brasil LTDA.